By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Monogram Biosciences 

345 Oyster Point Boulevard

South San Francisco  California  94080  U.S.A.
Phone: 650-635-1100 Fax: 650-635-1111


SEARCH JOBS

Monogram Biosciences has been at the forefront of individualized medicine since 1996. The company develops and commercializes innovative products to help guide and improve the treatment of infectious diseases and cancer.

  • Health care providers use our molecular diagnostics and testing services to match the underlying molecular elements of an individual patient’s disease to the drug best able to affect those elements. This results in optimized treatment regimens for patients and reduced healthcare costs.

  • Pharmaceutical companies use our services to develop new and improved antiviral therapeutics and vaccines, as well as targeted cancer therapeutics. We provide enhanced patient selection and monitoring capabilities throughout the development process.
We have developed HIV tests, or assays, to help make the complexities of antiretroviral therapy easier to manage.

We have also developed oncology products to help accelerate the development of targeted cancer therapeutics.

Last Updated: 11-13-06


Key Statistics


Email: info@monogrambio.com
Ownership: Public

Web Site: Monogram Biosciences
Employees:
Symbol: MGRM
 



Industry
Biotechnology






Company News
Laboratory Corporation of America Holdings (LabCorp) (LH) Introduces HCV Resistance Testing through Monogram Biosciences (MGRM) with the Launch of HCV GenoSure® NS3/4A 8/25/2011 10:30:06 AM
AIDS Researchers Isolate New Potent and Broadly Effective Antibodies Against HIV, International AIDS Vaccine Initiative, The Scripps Research Institute, Theraclone Sciences, Inc., and Monogram Biosciences (MGRM) Study 8/18/2011 7:50:02 AM
Laboratory Corporation of America Holdings (LabCorp) (LH) Successfully Completes Acquisition of Monogram Biosciences (MGRM) 8/5/2009 9:57:59 AM
Laboratory Corporation of America Holdings (LabCorp) (LH) Successfully Completes Cash Tender Offer for Outstanding Shares of Monogram Biosciences (MGRM) 8/4/2009 9:29:20 AM
Laboratory Corporation of America Holdings (LabCorp) (LH) Extends Tender Offer for All Outstanding Shares of Monogram Biosciences (MGRM) 7/28/2009 11:59:50 AM
Laboratory Corporation of America Holdings (LabCorp) (LH)'s Acquisition of Monogram Biosciences (MGRM) Clears Antitrust Review 7/17/2009 8:26:00 AM
Laboratory Corporation of America Holdings (LabCorp) (LH) Commences Cash Tender Offer for All Outstanding Shares of Monogram Biosciences (MGRM) 7/1/2009 8:48:11 AM
Laboratory Corporation of America Holdings (LabCorp) (LH) Enters Definitive Agreement to Acquire Monogram Biosciences (MGRM) for $155 Million 6/23/2009 7:14:58 AM
Monogram Biosciences (MGRM) Presents Three Studies at The 45th American Society of Clinical Oncology Meeting Describing HERmark's(R) Ability to Select Trastuzumab Responders and Non-Responders 6/2/2009 10:03:11 AM
Monogram Biosciences (MGRM) Announces Several Presentations to Be Made on HERmark(R) Breast Cancer Assay and VeraTag(TM) Technology at the 45th American Society of Clinical Oncology Meeting 5/27/2009 8:27:42 AM
12345678910...
//-->